SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Traynor Bryan J.)
 

Sökning: WFRF:(Traynor Bryan J.) > Frequency of the C9...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006099naa a2200997 4500
001oai:lup.lub.lu.se:fc9f0259-c727-40ec-b56a-3ef69c2284fd
003SwePub
008160401s2012 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/24946162 URI
024a https://doi.org/10.1016/S1474-4422(12)70043-12 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Majounie, Elisa4 aut
2451 0a Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
264 1c 2012
338 a electronic2 rdacarrier
520 a Background We aimed to accurately estimate the frequency of a hexanucleotide repeat expansion in C9orf72 that has been associated with a large proportion of cases of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Methods We screened 4448 patients diagnosed with ALS (El Escorial criteria) and 1425 patients with FTD (Lund-Manchester criteria) from 17 regions worldwide for the GGGGCC hexanucleotide expansion using a repeat-primed PCR assay. We assessed familial disease status on the basis of self-reported family history of similar neurodegenerative diseases at the time of sample collection. We compared haplotype data for 262 patients carrying the expansion with the known Finnish founder risk haplotype across the chromosomal locus. We calculated age-related penetrance using the Kaplan-Meier method with data for 603 individuals with the expansion. Findings In patients with sporadic ALS, we identified the repeat expansion in 236 (7.0%) of 3377 white individuals from the USA, Europe, and Australia, two (4.1%) of 49 black individuals from the USA, and six (8.3%) of 72 Hispanic individuals from the USA. The mutation was present in 217 (39.3%) of 552 white individuals with familial MS from Europe and the USA. 59 (6.0%) of 981 white Europeans with sporadic FTD had the mutation, as did 99 (24.8%) of 400 white Europeans with familial FTD. Data for other ethnic groups were sparse, but we identified one Asian patient with familial ALS (from 20 assessed) and two with familial FTD (from three assessed) who carried the mutation. The mutation was not carried by the three Native Americans or 360 patients from Asia or the Pacific Islands with sporadic MS who were tested, or by 41 Asian patients with sporadic FTD. All patients with the repeat expansion had (partly or fully) the founder haplotype, suggesting a one-off expansion occurring about 1500 years ago. The pathogenic expansion was non-penetrant in individuals younger than 35 years, 50% penetrant by 58 years, and almost fully penetrant by 80 years. Interpretation A common Mendelian genetic lesion in C9472 is implicated in many cases of sporadic and familial ALS and FTD. Testing for this pathogenic expansion should be considered in the management and genetic counselling of patients with these fatal neurodegenerative diseases.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng
700a Renton, Alan E.4 aut
700a Mok, Kin4 aut
700a Dopper, Elise G. P.4 aut
700a Waite, Adrian4 aut
700a Rollinson, Sara4 aut
700a Chio, Adrian4 aut
700a Restagno, Gabriella4 aut
700a Nicolaou, Nayia4 aut
700a Simon-Sanchez, Javier4 aut
700a van Swieten, John C.4 aut
700a Abramzon, Yevgeniya4 aut
700a Johnson, Janel O.4 aut
700a Sendtner, Michael4 aut
700a Pamphlett, Roger4 aut
700a Orrell, Richard W.4 aut
700a Mead, Simon4 aut
700a Sidle, Katie C.4 aut
700a Houlden, Henry4 aut
700a Rohrer, Jonathan D.4 aut
700a Morrison, Karen E.4 aut
700a Pall, Hardev4 aut
700a Talbot, Kevin4 aut
700a Ansorge, Olaf4 aut
700a Hernandez, Dena G.4 aut
700a Arepalli, Sampath4 aut
700a Sabatelli, Mario4 aut
700a Mora, Gabriele4 aut
700a Corbo, Massimo4 aut
700a Giannini, Fabio4 aut
700a Calvo, Andrea4 aut
700a Englund, Elisabetu Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)pat-een
700a Borghero, Giuseppe4 aut
700a Foris, Gian Luca4 aut
700a Remes, Anne M.4 aut
700a Laaksovirta, Hannu4 aut
700a McCluskey, Leo4 aut
700a Trojanowski, John Q.4 aut
700a Van Deerlin, Vivianna M.4 aut
700a Schellenberg, Gerard D.4 aut
700a Nalls, Michael A.4 aut
700a Drory, Vivian E.4 aut
700a Lu, Chin-Song4 aut
700a Yeh, Tu-Hsueh4 aut
700a Ishiura, Hiroyuki4 aut
700a Takahashi, Yuji4 aut
700a Tsuji, Shoji4 aut
700a Le Ber, Isabelle4 aut
700a Brice, Alexis4 aut
700a Drepper, Carsten4 aut
700a Williams, Nigel4 aut
700a Kirby, Janine4 aut
700a Shaw, Pamela4 aut
700a Hardy, John4 aut
700a Tienari, Pentti J.4 aut
700a Heutink, Peter4 aut
700a Morris, Huw R.4 aut
700a Pickering-Brown, Stuart4 aut
700a Traynor, Bryan J.4 aut
710a Tumörmikromiljöb Sektion I4 org
773t Lancet Neurologyg 11:4, s. 323-330q 11:4<323-330x 1474-4465
856u https://portal.research.lu.se/files/2478407/2541052.pdfx primaryx freey FULLTEXT
856u http://dx.doi.org/10.1016/S1474-4422(12)70043-1y FULLTEXT
8564 8u https://lup.lub.lu.se/record/2494616
8564 8u https://doi.org/10.1016/S1474-4422(12)70043-1

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy